Entity Details
| Primary name |
AK1D1_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | P51857 |
| EntryName | AK1D1_HUMAN |
| FullName | Aldo-keto reductase family 1 member D1 |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 326 |
| SequenceStatus | complete |
| DateCreated | 1996-10-01 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cytoplasm |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR018170 | Aldo/keto reductase, conserved site | Site | Conserved site |
| IPR020471 | Aldo-keto reductase | Family | Family |
| IPR023210 | NADP-dependent oxidoreductase domain | Domain | Domain |
| IPR036812 | NADP-dependent oxidoreductase domain superfamily | Family | Homologous superfamily |
| IPR044483 | Aldo-keto reductase family 1 member D1 | Family | Family |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 235555 | OMIM | Congenital bile acid synthesis defect 2 (CBAS2) | A condition characterized by jaundice, intrahepatic cholestasis and hepatic failure. Patients with this liver disease show absence or low levels of chenodeoxycholic acid and cholic acid in plasma and urine. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
| Drug | Name | Source | Type |
| DB00548 | Azelaic acid | Drugbank | small molecule |
| DB00717 | Norethisterone | Drugbank | small molecule |
| DB00741 | Hydrocortisone | Drugbank | small molecule |
| DB01216 | Finasteride | Drugbank | small molecule |
| DB06077 | Lumateperone | Drugbank | small molecule |
| DB07447 | 5beta-dihydrotestosterone | Drugbank | small molecule |
| DB07557 | 3,20-Pregnanedione | Drugbank | small molecule |
Interactions
0 interactions
| Interactor | Partner | Sources | Publications | Link |